Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tango Therapeutics
Biotech
Tango dances away from preclinical work to extend cash runway
Bank balances were again in focus Monday, with Tango cutting preclinical work to stretch its runway and Avalo outlining options for preserving money.
Nick Paul Taylor
May 12, 2025 8:37am
Tango axes PRMT5 inhibitor, shifts focus to 2 sibling molecules
Nov 6, 2024 8:28am
Tango drops USP1 inhibitor over liver toxicity in phase 1 trial
May 23, 2024 8:11am
Mirati CEO exits—Chutes & Ladders
Aug 11, 2023 9:30am
Billy Dunn departs FDA—Chutes & Ladders
Mar 3, 2023 9:30am
Seagen finally finds new CEO—Chutes & Ladders
Nov 11, 2022 9:30am
